{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Notice\" and posted_year = 2020 sorted by posted_date descending", "rows": [["FDA-2016-N-0124-0410", "FDA", "FDA-2016-N-0124", "Consumer Antiseptic Rub Final Rule; Finding of Ineligibility for Inclusion in Final Monograph Questions and Answers; Guidance for Industry; Small\nEntity Compliance Guide; Availability", "Notice", "Notice of Availability", "2020-12-31T05:00:00Z", 2020, 12, "2020-12-31T05:00:00Z", null, "2020-12-31T14:14:51Z", "2020-28929", 0, 0, "09000064849d654d"], ["FDA-2014-D-1804-0073", "FDA", "FDA-2014-D-1804", "Product Labeling for Laparoscopic Power Morcellators; Guidance for\nIndustry and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2020-12-30T05:00:00Z", 2020, 12, "2020-12-30T05:00:00Z", null, "2020-12-30T13:31:56Z", "2020-28816", 0, 0, "09000064849d16c7"], ["FDA-2018-N-3233-0002", "FDA", "FDA-2018-N-3233", "Request for Nominations for Voting Members on a Public Advisory\nCommittee; Technical Electronic Product Radiation Safety Standards\nCommittee", "Notice", "Request for Nominations", "2020-12-30T05:00:00Z", 2020, 12, "2020-12-30T05:00:00Z", null, "2020-12-30T13:28:30Z", "2020-28833", 0, 0, "09000064849d18c9"], ["FDA-2020-N-2246-0001", "FDA", "FDA-2020-N-2246", "Fee Rates Under the Over-the-Counter Monograph Drug User Fee Program for Fiscal Year 2021", "Notice", "Announcement", "2020-12-29T05:00:00Z", 2020, 12, "2020-12-29T05:00:00Z", null, "2020-12-29T17:03:53Z", "2020-28714", 0, 0, "09000064849cfd28"], ["FDA-2010-N-0493-0013", "FDA", "FDA-2010-N-0493", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", "Notice of Approval", "2020-12-29T05:00:00Z", 2020, 12, "2020-12-29T05:00:00Z", null, "2020-12-29T17:10:19Z", "2020-28608", 0, 0, "09000064849cfdc6"], ["FDA-2017-N-2021-0007", "FDA", "FDA-2017-N-2021", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", "Notice of Approval", "2020-12-29T05:00:00Z", 2020, 12, "2020-12-29T05:00:00Z", null, "2020-12-29T17:10:55Z", "2020-28608", 0, 0, "09000064849cfe9f"], ["FDA-2017-N-1095-0009", "FDA", "FDA-2017-N-1095", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", "Notice of Approval", "2020-12-29T05:00:00Z", 2020, 12, "2020-12-29T05:00:00Z", null, "2020-12-29T17:12:08Z", "2020-28608", 0, 0, "09000064849cfe9d"], ["FDA-2012-N-0197-0010", "FDA", "FDA-2012-N-0197", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", "Notice of Approval", "2020-12-29T05:00:00Z", 2020, 12, "2020-12-29T05:00:00Z", null, "2020-12-29T17:12:34Z", "2020-28608", 0, 0, "09000064849cfe9c"], ["FDA-2011-N-0424-0011", "FDA", "FDA-2011-N-0424", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", "Notice of Approval", "2020-12-29T05:00:00Z", 2020, 12, "2020-12-29T05:00:00Z", null, "2020-12-29T17:11:23Z", "2020-28608", 0, 0, "09000064849cfe9e"], ["FDA-2020-N-2252-0001", "FDA", "FDA-2020-N-2252", "Interim Assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act; Public Meeting; Request for Comments", "Notice", "Request for Comments", "2020-12-28T05:00:00Z", 2020, 12, "2020-12-28T05:00:00Z", "2021-03-30T03:59:59Z", "2021-03-30T01:00:27Z", "2020-28602", 0, 0, "09000064849cc7ab"], ["FDA-2020-D-0530-0668", "FDA", "FDA-2020-D-0530", "Voluntary Disclosure of Sesame as an\nAllergen: Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request; Extension of Comment Period", "Notice", "Notice of Availability", "2020-12-28T05:00:00Z", 2020, 12, "2020-12-28T05:00:00Z", "2021-02-26T04:59:59Z", "2021-02-27T02:00:26Z", "2020-28559", 0, 0, "09000064849cc892"], ["FDA-2017-D-4303-0003", "FDA", "FDA-2017-D-4303", "Providing Regulatory Submissions in Electronic Format\u2014Content of the Risk Evaluation and Mitigation Strategies Document Using Structured Product Labeling; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-12-28T05:00:00Z", 2020, 12, "2020-12-28T05:00:00Z", null, "2020-12-28T16:56:08Z", "2020-28560", 0, 0, "09000064849cc7af"], ["FDA-2020-N-1440-0001", "FDA", "FDA-2020-N-1440", "Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments", "Notice", "Request for Comments", "2020-12-28T05:00:00Z", 2020, 12, "2020-12-28T05:00:00Z", "2021-02-09T04:59:59Z", "2021-02-10T02:00:46Z", "2020-28558", 0, 0, "09000064849cc88e"], ["FDA-2020-N-0008-0022", "FDA", "FDA-2020-N-0008", "Advisory Committee; Cellular, Tissue and Gene Therapies Advisory\nCommittee; Renewal", "Notice", "Renewals", "2020-12-28T05:00:00Z", 2020, 12, "2020-12-28T05:00:00Z", null, "2020-12-28T16:53:17Z", "2020-28561", 0, 0, "09000064849cc890"], ["FDA-2020-N-2272-0001", "FDA", "FDA-2020-N-2272", "Hospira, Inc., et al.; Withdrawal of Approval of 27 New Drug Applications", "Notice", "Withdrawal", "2020-12-23T05:00:00Z", 2020, 12, "2020-12-23T05:00:00Z", null, "2020-12-23T15:00:57Z", "2020-28346", 0, 0, "09000064849c0835"], ["FDA-2010-N-0155-0253", "FDA", "FDA-2010-N-0155", "Agency Information Collection Activities; Proposed Collection; Comment Request; Veterinary Feed Directive", "Notice", "60 Day Proposed Information Collection", "2020-12-23T05:00:00Z", 2020, 12, "2020-12-23T05:00:00Z", "2021-02-23T04:59:59Z", "2020-12-23T15:07:58Z", "2020-28353", 0, 0, "09000064849c0f93"], ["FDA-2020-N-2267-0001", "FDA", "FDA-2020-N-2267", "Endo Pharmaceuticals, Inc.; Withdrawal of Approval of a New Drug Application for OPANA (Oxymorphone Hydrochloride) Extended-Release Tablets", "Notice", "Withdrawal", "2020-12-23T05:00:00Z", 2020, 12, "2020-12-23T05:00:00Z", null, "2020-12-23T15:11:29Z", "2020-28283", 0, 0, "09000064849c0fe7"], ["FDA-2014-N-0386-0005", "FDA", "FDA-2014-N-0386", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Orphan Drugs", "Notice", "30 Day Proposed Information Collection", "2020-12-23T05:00:00Z", 2020, 12, "2020-12-23T05:00:00Z", "2021-01-23T04:59:59Z", "2021-01-23T02:02:30Z", "2020-28349", 0, 0, "09000064849c0f39"], ["FDA-2010-N-0161-0012", "FDA", "FDA-2010-N-0161", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Export of Food and Drug Administration-Regulated Products: Export Certificates", "Notice", "30 Day Proposed Information Collection", "2020-12-21T05:00:00Z", 2020, 12, "2020-12-21T05:00:00Z", "2021-01-21T04:59:59Z", "2020-12-21T13:22:19Z", "2020-28064", 0, 0, "09000064849ae940"], ["FDA-2020-N-1866-0002", "FDA", "FDA-2020-N-1866", "Wockhardt Ltd., et al.; Withdrawal of Approval of Nine Abbreviated New Drug Applications; Correction", "Notice", "Correction", "2020-12-21T05:00:00Z", 2020, 12, "2020-12-21T05:00:00Z", null, "2020-12-21T13:44:00Z", "2020-28081", 0, 0, "09000064849aef3a"], ["FDA-2020-P-1650-0003", "FDA", "FDA-2020-P-1650", "Determination That DOBUTREX (Dobutamine Hydrochloride), Equivalent 12.5 Milligram Base/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2020-12-21T05:00:00Z", 2020, 12, "2020-12-21T05:00:00Z", null, "2020-12-21T13:53:01Z", "2020-28080", 0, 0, "09000064849aefda"], ["FDA-2018-N-0417-0003", "FDA", "FDA-2018-N-0417", "Request for Nominations of Voting Members on a Public Advisory\nCommittee; National Mammography Quality Assurance Advisory\nCommittee", "Notice", "Advisory Committee", "2020-12-21T05:00:00Z", 2020, 12, "2020-12-21T05:00:00Z", null, "2020-12-21T13:33:01Z", "2020-28054", 0, 0, "09000064849aeb78"], ["FDA-2020-N-0001-0007", "FDA", "FDA-2020-N-0001", "Scientific and Ethical Considerations for the Inclusion of Pregnant Women in\nClinical Trials; Public Meeting", "Notice", "Public Meetings", "2020-12-21T05:00:00Z", 2020, 12, "2020-12-21T05:00:00Z", null, "2020-12-21T13:28:07Z", "2020-28069", 0, 0, "09000064849ae945"], ["FDA-2020-N-2217-0001", "FDA", "FDA-2020-N-2217", "Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drugs for Investigational Use", "Notice", "60 Day Proposed Information Collection", "2020-12-21T05:00:00Z", 2020, 12, "2020-12-21T05:00:00Z", "2021-02-20T04:59:59Z", "2021-02-20T02:00:29Z", "2020-28068", 0, 0, "09000064849aef84"], ["FDA-2014-N-1072-0011", "FDA", "FDA-2014-N-1072", "Agency Information Collection\nActivities; Submission for Office of\nManagement and Budget Review; Comment Request; Application for Participation in Food and Drug Administration Fellowship and Traineeship Programs", "Notice", "30 Day Proposed Information Collection", "2020-12-18T05:00:00Z", 2020, 12, "2020-12-18T05:00:00Z", "2021-01-20T04:59:59Z", "2020-12-18T14:46:28Z", "2020-27963", 0, 0, "09000064849a75bd"], ["FDA-2020-N-1359-0021", "FDA", "FDA-2020-N-1359", "Sugars That Are Metabolized Differently Than Traditional Sugars;\nExtension of Comment Period", "Notice", "Extension of Comment Period", "2020-12-18T05:00:00Z", 2020, 12, "2020-12-18T05:00:00Z", "2020-10-20T03:59:59Z", "2020-12-18T14:50:26Z", "2020-27749", 0, 0, "09000064849a7689"], ["FDA-2020-N-0026-0008", "FDA", "FDA-2020-N-0026", "Issuance of Priority Review Voucher: Rare Pediatric Disease Product", "Notice", "General Notice", "2020-12-17T05:00:00Z", 2020, 12, "2020-12-17T05:00:00Z", null, "2020-12-17T18:16:44Z", "2020-27760", 0, 0, "09000064849a4513"], ["FDA-2013-N-0520-0011", "FDA", "FDA-2013-N-0520", "Agency Information Collection Activities; Proposed Collection; Comment Request; Substances Prohibited From Use in Animal Food or Feed", "Notice", "60 Day Proposed Information Collection", "2020-12-17T05:00:00Z", 2020, 12, "2020-12-17T05:00:00Z", "2021-02-17T04:59:59Z", "2020-12-17T18:14:11Z", "2020-27746", 0, 0, "09000064849a43f7"], ["FDA-2020-D-2214-0001", "FDA", "FDA-2020-D-2214", "Dry Eye: Developing Drugs for Treatment; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-12-17T05:00:00Z", 2020, 12, "2020-12-17T05:00:00Z", "2021-03-18T03:59:59Z", "2022-09-12T19:47:56Z", "2020-27762", 0, 0, "09000064849a4491"], ["FDA-2019-D-3679-0014", "FDA", "FDA-2019-D-3679", "Interacting With the Food and Drug Administration on Complex Innovative Trial Designs for Drugs and Biological Products; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-12-17T05:00:00Z", 2020, 12, "2020-12-17T05:00:00Z", null, "2020-12-17T19:10:20Z", "2020-27813", 0, 0, "09000064849a443c"], ["FDA-2020-N-0026-0007", "FDA", "FDA-2020-N-0026", "Issuance of Priority Review Voucher; Rare Pediatric Disease Product", "Notice", "General Notice", "2020-12-17T05:00:00Z", 2020, 12, "2020-12-17T05:00:00Z", null, "2020-12-17T16:38:06Z", "2020-27778", 0, 0, "09000064849a448f"], ["FDA-2018-N-0074-0005", "FDA", "FDA-2018-N-0074", "Agency Information Collection Activities; Proposed Collection; Comment Request; State Enforcement Notifications", "Notice", "60 Day Proposed Information Collection", "2020-12-17T05:00:00Z", 2020, 12, "2020-12-17T05:00:00Z", "2021-02-17T04:59:59Z", "2020-12-17T18:08:40Z", "2020-27748", 0, 0, "09000064849a43bc"], ["FDA-2014-D-1167-0021", "FDA", "FDA-2014-D-1167", "Controlled Correspondence Related to Generic Drug Development; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-12-17T05:00:00Z", 2020, 12, "2020-12-17T05:00:00Z", null, "2020-12-17T19:19:44Z", "2020-27810", 0, 0, "09000064849a4518"], ["FDA-2020-N-2197-0001", "FDA", "FDA-2020-N-2197", "VistaPharm, Inc., et al.; Withdrawal of Approval of 10 Abbreviated New Drug\nApplications", "Notice", "Withdrawal", "2020-12-11T05:00:00Z", 2020, 12, "2020-12-11T05:00:00Z", null, "2020-12-11T14:19:32Z", "2020-27303", 0, 0, "0900006484998516"], ["FDA-2015-D-3787-0015", "FDA", "FDA-2015-D-3787", "Electromagnetic Compatibility of Medical Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period", "Notice", "Extension of Comment Period", "2020-12-11T05:00:00Z", 2020, 12, "2020-12-11T05:00:00Z", "2021-02-17T04:59:59Z", "2020-12-11T14:25:30Z", "2020-27350", 0, 0, "09000064849985cd"], ["FDA-2019-D-1650-0008", "FDA", "FDA-2019-D-1650", "Performance Criteria for Safety and Performance Based Pathway; Guidances for Industry and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2020-12-11T05:00:00Z", 2020, 12, "2020-12-11T05:00:00Z", null, "2020-12-11T13:54:17Z", "2020-27248", 0, 0, "0900006484998722"], ["FDA-2019-D-1647-0005", "FDA", "FDA-2019-D-1647", "Performance Criteria for Safety and Performance Based Pathway; Guidances for Industry and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2020-12-11T05:00:00Z", 2020, 12, "2020-12-11T05:00:00Z", null, "2020-12-11T13:51:06Z", "2020-27248", 0, 0, "0900006484998515"], ["FDA-2019-N-4203-0033", "FDA", "FDA-2019-N-4203", "Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Renewal", "Notice", "Advisory Committee", "2020-12-11T05:00:00Z", 2020, 12, "2020-12-11T05:00:00Z", null, "2020-12-11T14:22:38Z", "2020-27289", 0, 0, "0900006484998591"], ["FDA-2020-D-0064-0005", "FDA", "FDA-2020-D-0064", "Pre-Submission Consultation Process for Animal Food Additive Petitions or Generally Recognized as Safe Notices; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-12-11T05:00:00Z", 2020, 12, "2020-12-11T05:00:00Z", null, "2020-12-11T13:31:44Z", "2020-27256", 0, 0, "0900006484998048"], ["FDA-2020-N-2226-0001", "FDA", "FDA-2020-N-2226", "Cheese Products Deviating from Identity Standard; Temporary Permit for Market Testing", "Notice", "General Notice", "2020-12-11T05:00:00Z", 2020, 12, "2020-12-11T05:00:00Z", null, "2020-12-11T13:46:57Z", "2020-27197", 0, 0, "0900006484998093"], ["FDA-2019-D-1652-0008", "FDA", "FDA-2019-D-1652", "Performance Criteria for Safety and Performance Based Pathway; Guidances for Industry and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2020-12-11T05:00:00Z", 2020, 12, "2020-12-11T05:00:00Z", null, "2020-12-11T13:52:37Z", "2020-27248", 0, 0, "0900006484998721"], ["FDA-2010-D-0529-0033", "FDA", "FDA-2010-D-0529", "Qualification Process for Drug Development Tools; Guidance for Industry; Availability; Correction", "Notice", "Notice of Availability", "2020-12-11T05:00:00Z", 2020, 12, "2020-12-11T05:00:00Z", null, "2020-12-11T13:39:39Z", "2020-27288", 0, 0, "090000648499804d"], ["FDA-2020-N-2196-0001", "FDA", "FDA-2020-N-2196", "Allergan Pharmaceuticals International, Ltd.; Withdrawal of Approval of a New Drug Application for ASACOL (Mesalamine) Delayed-Release Tablets, 400 Milligrams", "Notice", "Withdrawal", "2020-12-10T05:00:00Z", 2020, 12, "2020-12-10T05:00:00Z", null, "2020-12-10T12:59:11Z", "2020-27082", 0, 0, "0900006484995521"], ["FDA-2020-N-2227-0001", "FDA", "FDA-2020-N-2227", "Food and Drug Administration FiscalbYear 2020 Performance Review Board", "Notice", "Announcement", "2020-12-10T05:00:00Z", 2020, 12, "2020-12-10T05:00:00Z", null, "2020-12-10T12:50:15Z", "2020-27123", 0, 0, "090000648499376c"], ["FDA-2014-N-1076-0007", "FDA", "FDA-2014-N-1076", "Agency Information Collection Activities; Proposed Co llection;\nComment Request; Formal Dispute Resolution: Scientific and Technical\nIssues Related to Pharmaceutical Current Good Manufacturing Practice", "Notice", "60 Day Proposed Information Collection", "2020-12-09T05:00:00Z", 2020, 12, "2020-12-09T05:00:00Z", "2021-02-09T04:59:59Z", "2020-12-09T13:49:47Z", "2020-27060", 0, 0, "090000648498fb9a"], ["FDA-2020-D-0770-0001", "FDA", "FDA-2020-D-0770", "Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-12-09T05:00:00Z", 2020, 12, "2020-12-09T05:00:00Z", null, "2021-03-15T21:11:29Z", "2020-27057", 0, 0, "090000648498fbf4"], ["FDA-2014-D-0622-0020", "FDA", "FDA-2014-D-0622", "Best Practices in Developing Proprietary Names for Human Prescription Drug Products; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-12-09T05:00:00Z", 2020, 12, "2020-12-09T05:00:00Z", null, "2020-12-09T13:40:47Z", "2020-27058", 0, 0, "090000648498fb58"], ["FDA-2020-N-0026-0006", "FDA", "FDA-2020-N-0026", "Issuance of Priority Review Voucher; Rare Pediatric Disease Product", "Notice", "Announcement", "2020-12-07T05:00:00Z", 2020, 12, "2020-12-07T05:00:00Z", null, "2020-12-07T16:10:20Z", "2020-26801", 0, 0, "0900006484989f80"], ["FDA-2019-N-5900-0012", "FDA", "FDA-2019-N-5900", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion", "Notice", "30 Day Proposed Information Collection", "2020-12-07T05:00:00Z", 2020, 12, "2020-12-07T05:00:00Z", "2021-01-07T04:59:59Z", "2020-12-08T02:00:52Z", "2020-26799", 0, 0, "0900006484989f3f"], ["FDA-2018-N-1768-0002", "FDA", "FDA-2018-N-1768", "Advisory Committee; Pharmacy Compounding Advisory Committee;\nRenewal", "Notice", "Committee Renewal", "2020-12-04T05:00:00Z", 2020, 12, "2020-12-04T05:00:00Z", null, "2020-12-04T14:09:26Z", "2020-26696", 0, 0, "0900006484985b73"], ["FDA-2020-N-2216-0001", "FDA", "FDA-2020-N-2216", "Revocation of Authorizations of Emergency Use of Certain Medical\nDevices During COVID\u201319; Availability", "Notice", "Announcement", "2020-12-04T05:00:00Z", 2020, 12, "2020-12-04T05:00:00Z", null, "2020-12-04T13:25:15Z", "2020-26697", 0, 0, "0900006484985a7a"], ["FDA-2017-N-6397-0010", "FDA", "FDA-2017-N-6397", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Food Labeling; Calorie Labeling of Articles of Food in\nVending Machines and Nutrition Labeling of Standard Menu Items in\nRestaurants and Similar Retail Food Establishments", "Notice", "60 Day Proposed Information Collection", "2020-12-04T05:00:00Z", 2020, 12, "2020-12-04T05:00:00Z", "2021-02-03T04:59:59Z", "2021-01-26T02:01:19Z", "2020-26695", 0, 0, "0900006484985c24"], ["FDA-2019-D-4739-0016", "FDA", "FDA-2019-D-4739", "Requesting FDA Feedback on Combination Products; Guidance for\nIndustry and FDA Staff; Availability", "Notice", "Notice of Availability", "2020-12-04T05:00:00Z", 2020, 12, "2020-12-04T05:00:00Z", null, "2020-12-04T14:14:50Z", "2020-26700", 0, 0, "0900006484985b24"], ["FDA-2017-D-5739-0009", "FDA", "FDA-2017-D-5739", "Formal Meetings Between the Food and Drug Administration and\nAbbreviated New Drug Application Applicants of Complex Products Under Generic Drug User Fee Amendments; Guidance for Industry; Availability; Correction", "Notice", "Notice of Availability", "2020-12-04T05:00:00Z", 2020, 12, "2020-12-04T05:00:00Z", null, "2020-12-04T13:53:26Z", "2020-26691", 0, 0, "0900006484985c2a"], ["FDA-2017-P-5787-0235", "FDA", "FDA-2017-P-5787", "Petition Supplement 2 Post-Finasteride Syndrome Foundation", "Notice", "Background Material", "2020-12-03T05:00:00Z", 2020, 12, null, null, "2020-12-03T17:17:17Z", null, 0, 0, "0900006484984494"], ["FDA-2017-P-5787-0234", "FDA", "FDA-2017-P-5787", "Petition Supplement 1 Post-Finasteride Syndrome Foundation", "Notice", "Background Material", "2020-12-03T05:00:00Z", 2020, 12, null, null, "2020-12-03T17:16:41Z", null, 0, 0, "0900006484984493"], ["FDA-2020-N-2242-0001", "FDA", "FDA-2020-N-2242", "Vaccines and Related Biological Products Advisory Committee; Notice\nof Meeting; Establishment of a Public Docket; Request for Comments", "Notice", "Public Hearings", "2020-12-03T05:00:00Z", 2020, 12, "2020-12-03T05:00:00Z", "2020-12-17T04:59:59Z", "2020-12-18T02:00:39Z", "2020-26704", 0, 0, "090000648498419b"], ["FDA-2011-N-0016-0013", "FDA", "FDA-2011-N-0016", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2020-12-02T05:00:00Z", 2020, 12, "2020-12-02T05:00:00Z", null, "2020-12-02T15:02:15Z", "2020-26571", 0, 0, "09000064849819f5"], ["FDA-2010-N-0622-0011", "FDA", "FDA-2010-N-0622", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2020-12-02T05:00:00Z", 2020, 12, "2020-12-02T05:00:00Z", null, "2020-12-02T15:04:53Z", "2020-26571", 0, 0, "09000064849819f3"], ["FDA-2009-N-0501-0023", "FDA", "FDA-2009-N-0501", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2020-12-02T05:00:00Z", 2020, 12, "2023-04-04T04:00:00Z", null, "2023-04-04T15:33:25Z", "2020-26571", 0, 0, "09000064849819f8"], ["FDA-2019-N-6098-0009", "FDA", "FDA-2019-N-6098", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2020-12-02T05:00:00Z", 2020, 12, "2020-12-02T05:00:00Z", null, "2020-12-02T14:46:49Z", "2020-26571", 0, 0, "09000064849819f6"], ["FDA-1987-P-0074-0007", "FDA", "FDA-1987-P-0074", "Canned Pacific Salmon Deviating From Identity Standard; Amendment of\nTemporary Marketing Permit", "Notice", "Correction", "2020-12-02T05:00:00Z", 2020, 12, "2020-12-02T05:00:00Z", null, "2020-12-02T14:37:41Z", "2020-26533", 0, 0, "0900006484981905"], ["FDA-2010-N-0190-0004", "FDA", "FDA-2010-N-0190", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Infant Formula Requirements", "Notice", "60 Day Proposed Information Collection", "2020-12-02T05:00:00Z", 2020, 12, "2020-12-02T05:00:00Z", "2021-02-02T04:59:59Z", "2021-02-02T02:00:58Z", "2020-26537", 0, 0, "0900006484981343"], ["FDA-2013-N-1119-0015", "FDA", "FDA-2013-N-1119", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2020-12-02T05:00:00Z", 2020, 12, "2020-12-02T05:00:00Z", null, "2020-12-02T14:52:37Z", "2020-26571", 0, 0, "090000648498138f"], ["FDA-2019-N-1845-0136", "FDA", "FDA-2019-N-1845", "Fixed-Quantity Unit-of-Use Blister-Packaging for Certain Immediate-\nRelease Opioid Analgesics for Treatment of Acute Pain; Establishment of a Public Docket; Request for Comments; Reopening of the Comment  Period and Provision of Additional Information and Analysis", "Notice", "Request for Comments", "2020-12-01T05:00:00Z", 2020, 12, "2020-12-01T05:00:00Z", "2021-02-02T04:59:59Z", "2021-02-02T02:00:58Z", "2020-26504", 0, 0, "090000648497f5d1"], ["FDA-2020-D-1794-0001", "FDA", "FDA-2020-D-1794", "Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study Design, Data Analysis, and Clinical Implications; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-12-01T05:00:00Z", 2020, 12, "2020-12-01T05:00:00Z", "2021-03-02T04:59:59Z", "2021-03-02T02:00:56Z", "2020-26510", 0, 0, "090000648497f79e"], ["FDA-2011-N-0076-0013", "FDA", "FDA-2011-N-0076", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Electronic\nRecords; Electronic Signatures", "Notice", "30 Day Proposed Information Collection", "2020-12-01T05:00:00Z", 2020, 12, "2020-12-01T05:00:00Z", "2021-01-01T04:59:59Z", "2023-08-31T17:40:52Z", "2020-26487", 0, 0, "090000648497f743"], ["FDA-2020-N-1671-0003", "FDA", "FDA-2020-N-1671", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Good Laboratory\nPractice for Nonclinical Laboratory Studies", "Notice", "30 Day Proposed Information Collection", "2020-12-01T05:00:00Z", 2020, 12, "2020-12-01T05:00:00Z", "2021-01-01T04:59:59Z", "2020-12-01T15:39:21Z", "2020-26502", 0, 0, "090000648497f7a5"], ["FDA-2020-N-1337-0003", "FDA", "FDA-2020-N-1337", "John Kapoor: Final Debarment Order", "Notice", "Statutory Debarment", "2020-11-30T05:00:00Z", 2020, 11, "2020-11-30T05:00:00Z", null, "2020-11-30T13:47:21Z", "2020-26262", 0, 0, "090000648497c3e1"], ["FDA-2019-N-4248-0002", "FDA", "FDA-2019-N-4248", "Barry J. Cadden: Final Debarment Order", "Notice", "Statutory Debarment", "2020-11-30T05:00:00Z", 2020, 11, "2020-11-30T05:00:00Z", null, "2020-11-30T13:26:47Z", "2020-26255", 0, 0, "090000648497c22c"], ["FDA-2020-N-1255-0002", "FDA", "FDA-2020-N-1255", "Tuan Anh Tran: Final Debarment Order", "Notice", "Statutory Debarment", "2020-11-30T05:00:00Z", 2020, 11, "2020-11-30T05:00:00Z", null, "2020-11-30T13:41:46Z", "2020-26250", 0, 0, "090000648497c353"], ["FDA-2020-N-1347-0002", "FDA", "FDA-2020-N-1347", "Michael L. Babich: Final Debarment Order", "Notice", "Statutory Debarment", "2020-11-27T05:00:00Z", 2020, 11, "2020-11-27T05:00:00Z", null, "2020-11-27T13:49:00Z", "2020-26226", 0, 0, "09000064849787fd"], ["FDA-2020-N-1736-0009", "FDA", "FDA-2020-N-1736", "Potential Approach for Ranking of Antimicrobial Drugs According to\nTheir Importance in Human Medicine: A Risk Management Tool for\nAntimicrobial New Animal Drugs; Extension of Comment Period", "Notice", "Extension of Comment Period", "2020-11-27T05:00:00Z", 2020, 11, "2020-11-27T05:00:00Z", null, "2021-04-03T01:00:54Z", "2020-26182", 0, 0, "09000064849787ac"], ["FDA-2020-N-1898-0036", "FDA", "FDA-2020-N-1898", "Vaccines and Related Biological Products Advisory Committee; Notice\nof Meeting; Establishment of a Public Docket; Request for Comments", "Notice", "Public Meetings", "2020-11-27T05:00:00Z", 2020, 11, "2020-11-27T05:00:00Z", "2020-12-10T04:59:59Z", "2020-12-11T02:00:44Z", "2020-26229", 0, 0, "0900006484978404"], ["FDA-2016-D-4437-0005", "FDA", "FDA-2016-D-4437", "In-Use Stability Studies and Associated Labeling Statements for\nMultiple-Dose Injectable Animal Drug Products; Guidance for Industry;\nAvailability", "Notice", "Notice of Availability", "2020-11-27T05:00:00Z", 2020, 11, "2020-11-27T05:00:00Z", null, "2020-11-27T13:36:35Z", "2020-26183", 0, 0, "09000064849787ae"], ["FDA-2019-N-3077-0013", "FDA", "FDA-2019-N-3077", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Obtaining\nInformation To Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities", "Notice", "30 Day Proposed Information Collection", "2020-11-25T05:00:00Z", 2020, 11, "2020-11-25T05:00:00Z", "2020-12-29T04:59:59Z", "2020-12-27T02:02:12Z", "2020-26066", 0, 0, "0900006484975894"], ["FDA-2020-N-1677-0005", "FDA", "FDA-2020-N-1677", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Recordkeeping\nand Reporting Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing Material From Cattle", "Notice", "30 Day Proposed Information Collection", "2020-11-25T05:00:00Z", 2020, 11, "2020-11-25T05:00:00Z", "2020-12-29T04:59:59Z", "2020-11-26T02:00:36Z", "2020-26059", 0, 0, "0900006484975e11"], ["FDA-2009-N-0380-0012", "FDA", "FDA-2009-N-0380", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Product\nJurisdiction and Combination Products", "Notice", "30 Day Proposed Information Collection", "2020-11-25T05:00:00Z", 2020, 11, "2020-11-25T05:00:00Z", "2020-12-29T04:59:59Z", "2020-11-25T14:13:57Z", "2020-26062", 0, 0, "09000064849757af"], ["FDA-2017-D-5739-0007", "FDA", "FDA-2017-D-5739", "Formal Meetings Between the Food and Drug Administration and\nAbbreviated New Drug Application Applicants of Complex Products Under Generic Drug User Fee Amendments; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-11-25T05:00:00Z", 2020, 11, "2020-11-25T05:00:00Z", null, "2020-11-25T14:24:31Z", "2020-26050", 0, 0, "0900006484975d73"], ["FDA-2010-D-0529-0031", "FDA", "FDA-2010-D-0529", "Qualification Process for Drug Development Tools; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-11-25T05:00:00Z", 2020, 11, "2020-11-25T05:00:00Z", null, "2020-11-25T14:16:53Z", "2020-26051", 0, 0, "090000648497584a"], ["FDA-2020-Z-2200-0002", "FDA", "FDA-2020-Z-2200", "Termination of the Food and Drug Administration's Unapproved Drugs Initiative", "Notice", "General Notice", "2020-11-25T05:00:00Z", 2020, 11, "2020-11-25T05:00:00Z", null, "2020-11-27T16:25:15Z", "2020-26133", 0, 0, "0900006484975dc2"], ["FDA-2020-D-1848-0001", "FDA", "FDA-2020-D-1848", "Clinical Drug Interaction Studies With Combined Oral Contraceptives; Draft\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2020-11-23T05:00:00Z", 2020, 11, "2020-11-23T05:00:00Z", "2021-02-23T04:59:59Z", "2021-02-23T02:00:36Z", "2020-25744", 0, 0, "090000648497009b"], ["FDA-2018-D-1752-0028", "FDA", "FDA-2018-D-1752", "Public Availability of Lists of Retail Consignees To Effectuate Certain\nHuman and Animal Food Recalls; Guidance for Industry and Food and\nDrug Administration Staff; Availability", "Notice", "Notice of Availability", "2020-11-23T05:00:00Z", 2020, 11, "2020-11-23T05:00:00Z", null, "2020-11-23T14:18:01Z", "2020-25719", 0, 0, "0900006484970634"], ["FDA-2017-N-6455-0004", "FDA", "FDA-2017-N-6455", "Agency Information Collection Activities; Proposed Collection; Comment Request; Consultation Procedures: Foods Derived From New Plant Varieties", "Notice", "60 Day Proposed Information Collection", "2020-11-23T05:00:00Z", 2020, 11, "2020-11-23T05:00:00Z", "2021-01-23T04:59:59Z", "2020-11-23T14:11:23Z", "2020-25752", 0, 0, "0900006484970095"], ["FDA-2018-D-0943-0010", "FDA", "FDA-2018-D-0943", "Elemental Impurities in Animal Drug Products\u2014Questions and Answers;\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2020-11-23T05:00:00Z", 2020, 11, "2020-11-23T05:00:00Z", null, "2020-11-23T14:16:00Z", "2020-25726", 0, 0, "0900006484970560"], ["FDA-2020-D-2107-0001", "FDA", "FDA-2020-D-2107", "Cross Labeling Oncology Drugs in Combination Drug Regimens; Draft\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2020-11-20T05:00:00Z", 2020, 11, "2020-11-20T05:00:00Z", "2021-01-20T04:59:59Z", "2021-01-20T02:02:52Z", "2020-25737", 0, 0, "090000648496ac8d"], ["FDA-2020-N-1584-0002", "FDA", "FDA-2020-N-1584", "Authorization of Emergency Use of Certain Medical Devices During\nCOVID\u201319; Availability", "Notice", "General Notice", "2020-11-20T05:00:00Z", 2020, 11, "2020-11-20T05:00:00Z", null, "2020-11-20T15:33:21Z", "2020-25603", 0, 0, "090000648496ac8a"], ["FDA-2011-D-0611-0081", "FDA", "FDA-2011-D-0611", "Biosimilarity and Interchangeability: Additional Draft Q&As on Biosimilar Development and the Biologics Price Competition and Innovation Act of 2009; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-11-20T05:00:00Z", 2020, 11, "2020-11-20T05:00:00Z", "2021-01-20T04:59:59Z", "2021-01-21T02:00:45Z", "2020-25606", 0, 0, "090000648496ac54"], ["FDA-2020-N-1394-0002", "FDA", "FDA-2020-N-1394", "Richard M. Simon: Final Debarment Order", "Notice", "Statutory Debarment", "2020-11-19T05:00:00Z", 2020, 11, "2020-11-19T05:00:00Z", null, "2020-11-19T14:02:33Z", "2020-25601", 0, 0, "0900006484968606"], ["FDA-2007-D-0369-0510", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry;\nAvailability", "Notice", "Notice of Availability", "2020-11-19T05:00:00Z", 2020, 11, "2020-11-19T05:00:00Z", "2021-01-20T04:59:59Z", "2020-11-19T14:06:28Z", "2020-25602", 0, 0, "09000064849686e1"], ["FDA-2013-N-1429-0020", "FDA", "FDA-2013-N-1429", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act and Associated Fees", "Notice", "30 Day Proposed Information Collection", "2020-11-18T05:00:00Z", 2020, 11, "2020-11-18T05:00:00Z", "2020-12-19T04:59:59Z", "2023-07-20T14:23:39Z", "2020-25411", 0, 0, "0900006484966148"], ["FDA-2020-D-1137-0060", "FDA", "FDA-2020-D-1137", "Guidance Documents Related to Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2020-11-18T05:00:00Z", 2020, 11, "2020-11-18T05:00:00Z", null, "2021-04-03T01:00:48Z", "2020-25399", 0, 0, "0900006484966237"], ["FDA-2013-D-0575-0040", "FDA", "FDA-2013-D-0575", "Agency Information Collection Activities; Proposed Collection; Comment Request; Expedited Programs for Serious Conditions\u2014 Drugs and Biologics", "Notice", "60 Day Proposed Information Collection", "2020-11-18T05:00:00Z", 2020, 11, "2020-11-18T05:00:00Z", "2021-01-20T04:59:59Z", "2021-01-21T02:00:41Z", "2020-25414", 0, 0, "090000648496582e"], ["FDA-2007-D-0369-0508", "FDA", "FDA-2007-D-0369", "Product-Specific Guidance for Tiotropium Bromide; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-11-18T05:00:00Z", 2020, 11, "2020-11-18T05:00:00Z", "2021-01-20T04:59:59Z", "2021-01-16T02:01:08Z", "2020-25412", 0, 0, "09000064849661a3"], ["FDA-2020-D-1138-0132", "FDA", "FDA-2020-D-1138", "Guidance Documents Related to Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2020-11-18T05:00:00Z", 2020, 11, "2020-11-18T05:00:00Z", null, "2020-11-18T13:30:14Z", "2020-25399", 0, 0, "0900006484965ca4"], ["FDA-2019-N-5843-0002", "FDA", "FDA-2019-N-5843", "Pharmacia and Upjohn Co., et al.; Withdrawal of Approval of 19 New Drug Applications; Correction", "Notice", "Correction", "2020-11-18T05:00:00Z", 2020, 11, "2020-11-18T05:00:00Z", null, "2020-11-18T13:15:03Z", "2020-25413", 0, 0, "09000064849661a2"], ["FDA-2015-D-3787-0008", "FDA", "FDA-2015-D-3787", "Electromagnetic Compatibility of Medical Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2020-11-17T05:00:00Z", 2020, 11, "2020-11-17T05:00:00Z", "2021-01-20T04:59:59Z", "2021-01-15T02:01:09Z", "2020-25306", 0, 0, "0900006484963731"], ["FDA-2020-N-2030-0001", "FDA", "FDA-2020-N-2030", "Agency Information Collection Activities; Proposed Collection; Comment Request; Application for Food and Drug Administration Approval To Market a New Drug", "Notice", "60 Day Proposed Information Collection", "2020-11-16T05:00:00Z", 2020, 11, "2020-11-16T05:00:00Z", "2021-01-16T04:59:59Z", "2020-11-16T13:30:51Z", "2020-25239", 0, 0, "0900006484960494"], ["FDA-2019-D-3592-0010", "FDA", "FDA-2019-D-3592", "Certificates of Confidentiality; Guidance for Sponsors, Sponsor-Investigators, Researchers, Industry, and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2020-11-16T05:00:00Z", 2020, 11, "2020-11-16T05:00:00Z", null, "2020-11-16T13:40:06Z", "2020-25238", 0, 0, "0900006484960498"], ["FDA-2009-D-0052-0016", "FDA", "FDA-2009-D-0052", "Documenting Electronic Data Files and\nStatistical Analysis Programs;\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2020-11-13T05:00:00Z", 2020, 11, "2020-11-13T05:00:00Z", null, "2020-11-13T15:21:33Z", "2020-25131", 0, 0, "090000648495bcbe"]], "truncated": false, "filtered_table_rows_count": 778, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice", "p2": "2020"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2020", "results": [{"value": "FDA", "label": "FDA", "count": 778, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Notice&posted_year=2020", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2020", "results": [{"value": "Notice", "label": "Notice", "count": 778, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2020", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2020", "results": [{"value": 2020, "label": 2020, "count": 778, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2020&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2020&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2020&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2020&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2020&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2020&_facet_date=last_modified"}], "next": "2020-11-13T05~3A00~3A00Z,FDA-2009-D-0052-0016", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2020&_next=2020-11-13T05~3A00~3A00Z%2CFDA-2009-D-0052-0016&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1295.864196959883, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}